MR imaging of the prostate and bladder

Seminars in Ultrasound CT and MRI

Volumn 19, Issue 1, 1998, Pages 67-89

  Cheng, David ^a   Tempany, Clare M C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENIGN TUMOR; BLADDER CANCER; BLADDER DISEASE; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; REVIEW; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0031892863     PISSN: 08872171     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2171(98)90025-7     Document Type: Article

References (102)

1. Wingo PA, Landis S, Ries LAG: An adjustment to the 1997 estimates for new prostate cancer cases. CA Cancer J Clin 47:239-242, 1997
2. Catalona WJ, Smith DS, Ratliff TL, et al: Detection of organ confined prostate cancer is increased through prostate-specific-antigen screening. JAMA 270:948-954, 1993
3. Cancer Facts and Figures - 1997. American Cancer Society, 1997, pp 15, 17
4. Miller GJ, Cygnan JM: Morphology of prostate cancer: The effects of multifocality on histologic grade, tumor volume, and capsule penetration. J Urol 152:1709, 1994
5. Pollack HM, Resnick MI: Prostate specific antigen and screening for prostate cancer: Much ado about something? Radiology 189:353-356, 1993
6. Woolf SH: Screening for prostate cancer with prostate-specific antigen. N Engl J Med 333:1401, 1995
7. Catalona WJ, Smith DS, Ornstein DK: Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/ml and benign prostate examination. JAMA 277:1452-1456, 1997
8. Catalona WJ, Smith DS, Ratliff TL, et al: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324:1156-1161, 1991
9. Carter HB, Epstein JI, Chan DW, et al: Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer. JAMA 277:1456-1460, 1997
10. Andriole GL, Telle WB, Coplen DE, et al: PSA index (PSAI) as a predictor of prostate cancer in men with persistent serum PSA elevation. J Urol 147:387A, 1992 (abstr)
11. Benson MC, Whang IS, Olsson CA, et al: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 147:817-821, 1992
12. Brawer MK, Aramburu EA, Chen GL, et al: The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma. J Urol 150:369-373, 1993
13. Oesterling JE, Jacobsen SJ, Klee GG, et al: Free, complexed and total serum prostate specific antigen: The establishment of appropriate reference ranges for their concentrations and ratios. J Urol 154:1090-1095, 1995
14. Gittes RF: Carcinoma of the prostate. N Engl J Med 324:236-245, 1991
15. Renshaw A: Prostatic carcinoma: Diagnostic pathology and prognosis. MRI Clin N Am 4:439-448, 1996
16. Scardino PT, Shinohara K, Wheeler TM, et al: Staging of prostate cancer: Value of ultrasonography. Urol Clin N Am 16:713-734, 1989
17. Fair WR, Kakmon D: Carcinoma of the prostate: Diagnosis and staging. Current status and future prospects. World J Urol 1:3-11, 1983
18. Zietman AL, Shipley WU, Willett CG: Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications. Cancer 71:959-969, 1993 (Suppl)
19. Partin AW, Yoo J, Carter B, et al: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150:110-114, 1993
20. Partin AW, Kattan MW, Subong ENP, et al: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathologic stage of localized prostate cancer. JAMA 277:1445-1451, 1997
21. Chybowski FM, Keller JJ, Bergstralh EJ, et al: Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: Prostate specific antigen is superior to all other clinical parameters. J Urol 145:313-318, 1991
22. Oesterling JE, Martin SK, Bergstralh MS, et al: The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 269:57-60, 1993
23. D'Amico AV, Whittington R, Schnall M, et al: The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer. Cancer 75:2368-2372, 1995
24. McNeal JE: Prostate gland: Morphology and pathology, in Stamey TA (ed): Monographs in Urology. Princeton, NJ, Custom Publishing Services, 1983, pp 3-33
25. Secaf E, Nuruddin RN, Hricak H, et al: MR imaging of the seminal vesicles. Am J Roentgenol 156:989-994, 1991
26. Ayala AG, Ro JY, Babaian R, et al: The prostatic capsule: does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol 13:21-27, 1989
27. Epstein JI: The evaluation of radical prostatectomy specimens: Therapeutic and prognostic implications. Pathol Ann 26:159, 1991
28. Epstein JI, Carmichael MJ, Pizov G, et al: Influence of capsular penetration on progression following radical prostatectomy: A study of 196 cases with long term follow-up. J Urol 150:135-141, 1993
29. Jewett HJ: The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin N Am 2:105-170, 1975
30. Stamey TA, McNeal JE, Freiha FS, et al: Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 139:1235-1241, 1988
31. Hering F, Rist M, Roth J, et al: Does microinvasion of the capsule and/or micrometastases in regional lymph nodes influence disease-free survival after radical prostatectomy? Br J Urol 66:177-181, 1990
32. Stamey TA, Villers AA, McNeal JE, et al: Positive surgical margins at radical prostatectomy: Importance of the apical dissection. J Urol 143:1166-1173, 1990
33. Quinn SF, Franzini DA, Demlow TA, et al: MR imaging of prostate cancer with an endorectal surface coil technique: Correlation with whole-mount specimens. Radiology 190:323-327, 1994
34. Donahue RE, Miller GJ: Adenocarcinoma of the prostate: Biopsy to whole mount-Denver VA experience. Urol Clin N Am 18:449-452, 1991
35. Ackerman DA, Barry JM, Wicklund RA, et al: Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. J Urol 150:1845-1850, 1993
36. Schiebler ML, Schnall MD, Pollack HM, et al: Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 189:339-352, 1993
37. Villers J, McNeal JE, Redwine E, et al: The role of perineural space invasion in the local spread of prostate adenocarcinoma. J Urol 142:763-768, 1989
38. Wheeler TM: Anatomic considerations in prostate cancer. Urol Clin North Am 16:623-634, 1989
39. Epstein JI, Carmichael M, Walsh PC: Adenocarcinoma of the prostate invading the seminal vesicle: Definition and relation of tumor volume, grade, and margins of resection to prognosis. J Urol 149:1040-1045, 1993
40. Lange PH, Narayan P: Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy. Urology 21:113-118, 1983
41. Andriole GL, Coplen DE, Mikkelsen DJ, et al: Sonographic and pathological staging of patients with clinically localized prostate cancer. J Urol 142:1259-1261, 1989
42. Rifkin MD, Zerhouni EA, Gatsonis CA, et al: Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. N Engl J Med 323:621-626, 1990
43. Platt JF, Bree RL, Schwab RE: The accuracy of CT in the staging of carcinoma of the prostate. Am J Roentgenol 149:315-318, 1987
44. Hricak H, Dooms GC, Jeffrey RB, et al: Prostate carcinoma: staging by clinical assessment, CT, and MR imaging. Radiology 162:331-336, 1987
45. Martin JF, Hajek P, Baker L, et al: Inflatable surface coil for MR imaging of the prostate. Radiology 167:268-270, 1988
46. Schnall MD, Lenkinski RE, Pollack HM, et al: Prostate: MR imaging with an endorectal surface coil. Radiology 172:570-574, 1989
47. Listerud J, Lenkinski RE, Kressel HY, et al: The correction of nonuniform signal intensity profiles in magnetic resonance imaging. J Digit Imaging 2:2-8, 1989
48. Kier R, Wain S, Troiano R: Fast spin-echo MRI images of the pelvis with a phased-array coil: Value in localizing and staging prostate carcinoma. Am J Roentgenol 161:601-606, 1993
49. Huch Boni RA, Boner JA, Debatin JF, et al: Optimization of prostate carcinoma staging: Comparison of imaging and clinical methods. Clin Radiol 50:593-600, 1995
50. Mirowitz SA, Brown JJ, Heiken JP: Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging. Radiology 186:153-157, 1993
51. Hricak H, White S, Vigneron D, et al: Carcinoma of the prostate gland: MR imaging with pelvic phased array coils versus integrated endorectal-pelvic phased array coils. Radiology 193:703-709, 1994
52. Ellis JH, Tempany C, Sarin MS, et al: MR Imaging and sonography of early prostatic cancer: Pathologic and imaging features that influence identification and diagnosis. Am J Roentgenol 162:865-872, 1994
53. Jager GJ, Ruijter ETG, van de Kaa CA, et al: Local staging of prostate cancer with endorectal MR imaging: Correlation with histopathology. Am J Roentgenol 166:845-852, 1996
54. White S, Hricak H, Forstner R, et al: Prostate cancer: Effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 195:385-390, 1995
55. Ramchandani P, Schnall MD: Magnetic resonance imaging of the prostate. Semin Roentgenol 28:74-82, 1993
56. Tempany CMC, Partin AW, Zerhouni EA, et al: The influence of Finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia. The Prostate 22:39-42, 1993
57. Rahmouni AR, Yang A, Tempany CM et al: Accuracy of in vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr 16:935-940, 1992
58. Papanicolaou N, Pfister RC, Stafford SA, et al: Prostatic abscess: Imaging with transrectal sonography and MR. Am J Roentgenol 149:981, 1987
59. Chan TW, Kressel HY: Prostate and seminal vesicles after irradiation: MR appearance. JMRI 1:503-511, 1991
60. Gevenois PA, Sintzoff SA Jr., Stallenberg B, et al: Gadolinium-DOTA enhanced MR imaging of prostatic lesions: Preliminary results in 14 cases. J Belge Radiol 75:5-10, 1992
61. McNeal JE, Kindrachuk RA, Freiha FS, et al: Patterns of progression in prostate cancer. Lancet 1:60-63, 1986
62. Tempany CM, Rahmouni AD, Epstein JI, et al: Invasion of the neurovascular bundle by prostate cancer: evaluation with MR imaging. Radiology 181:107-112, 1991
63. Quint LE, Van Erp JS, Bland PH, et al: Carcinoma of the prostate: MR images obtained with body coils do not accurately reflect tumor volume. Am J Roentgenol 156:511-516, 1991
64. Bezzi M, Kressel HY, Allen KS, et al: Prostate carcinoma: Staging with MR imaging at 1.5 T. Radiology 169:339-346, 1989
65. Sommer FG, Nghiem HV, Herfkens R, et al: Determining the volume of prostatic carcinoma: Value of MR imaging with and external-array coil. Am J Roentgenol 161:81-86, 1993
66. Schnall MD, Imai Y, Tomaszewski J, et al: Prostate cancer: Local staging with endorectal surface coil MR imaging. Radiology 178:797-802, 1991
67. Chelsky MJ, Schnall MD, Seidmon EJ, et al: Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 150:391-395, 1993
68. Tempany CM, Zhou X, Zerhouni EA, et al: Staging of prostate cancer: Results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. Radiology 192:47-54, 1994
69. Outwater EK, Petersen RO, Siegelman ES, et al: Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. Radiology 193:333-339, 1994
70. Seltzer SE, Getty DJ, Tempany CMC, et al: Staging prostate cancer with MR imaging: A combined radiologist-computer system. Radiology 202:219-226, 1997
71. Oyen RH, Van Poppel HP, Ameye FE, et al: Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine needle aspiration biopsy: Prospective study of 285 patients. Radiology 190:315, 1994
72. Jager GJ, Barentsz JO, Oosterhof GO, et al: Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional T1-weighted magnetization-prepared-rapid gradient echo sequence. Am J Roentgenol 167: 1503-1507, 1996
73. Biondetti PR, Lee JKT, Ling D, et al: Clinical stage B prostate carcinoma: Staging with MR imaging. Radiology 162:323-329, 1987
74. Schiebler ML, Yankaskas B, Tempany C, et al: Efficacy of prostate specific antigen and magnetic resonance imaging in staging stage C adenocarcinoma of the prostate. Invest Radiol 27:575-577, 1992
75. Langlotz C, Schnall M, Pollack H: Staging of prostatic cancer: Accuracy of MR Imaging. With reply by Tempany, et al. Radiology 194:645-646, 1995
76. D'Amico AV, Whittington R, Malkowicz SB, et al: A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J Urol 154:131-138, 1995
77. Fisher MR, Hricak H, Tanagho EA: Urinary bladder MR imaging part I: Normal and benign conditions. Radiology 157:467-470, 1985
78. Tachibana M, Baba S, Deguchi N, et al: Efficacy of gadolinium-diethylene-triaminepentaacetic acid-enhanced magnetic resonance imaging for differentiation between superficial and muscle-invasive tumor of the bladder: A comparative study with computerized tomography and transurethral ultrasonography. J Urol 145:1169-1173, 1991
79. Neuerburg JM, Bohndorf K, Sohn M, et al: Staging of urinary bladder neoplasms with MR imaging: Is Gd-DTPA helpful? JCAT 15:780-786, 1991
80. Maya MM, Slywotsky C: Urinary bladder leiomyoma: Magnetic resonance imaging findings. Urol Radiol 14:197-199, 1992
81. Yoon IJ, Kim KH, Lee BH: Leiomyoma of the urinary bladder: MR findings. Am J Roentgenol 161:449-450, 1993
82. Tomoe H, Okumura T, Nakamura M, et al: Evaluation with MR imaging of leiomyoma of the bladder. Urol Int 46:349-351, 1991
83. Warshawsky R, Bow SN, Waldbaum RS, et al: Bladder pheochromocytoma with MR correlation. JCAT 13:714-716, 1989
84. Crecelius SA, Bellah R: Pheochromocytoma of the bladder in an adolescent: Sonographic and MR imaging findings. Am J Roentgenol 165:101-103, 1995
85. Hricak H: The bladder and female urethra, in Hricak H, Carrington BM (eds): MRI of the Pelvis: A Text Atlas. London, Martin Dunitz, 1991, pp 417-461
86. Barentsz JO, Ruijs SHJ, Strijk SP: The role of MR imaging in carcinoma of the urinary bladder. Am J Roentgenol 160:937-947, 1993
87. Holmang S, Hedelin H, Anderstrom C, et al: The importance of the depth of invasion in stage T1 bladder carcinoma: A prospective cohort study. J Urol 157:800-804, 1997
88. Tanimoto A, Yuasa Y, Imai Y, et al: Bladder tumor staging: Comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT. Radiology 185:741-747, 1992
89. Fisher MR, Hricak H, Tanagho EA: Urinary bladder MR imaging part II: Neoplasm. Radiology 157:471-477, 1985
90. Barentsz JO, Jager GJ, Mugler III JP, et al: Staging urinary bladder cancer: Value of T1-weighted 3D MP-RAGE and 2D SE sequences. Am J Roentgenol 164:109-115, 1995
91. Buy JN, Moss A, Guinet C, et al: MR Staging of bladder carcinoma: Correlation with pathologic findings. Radiology 169:695-700, 1988
92. Rholl KS, Lee JKT, Heiken JP, et al: Primary bladder carcinoma: Evaluation with MR imaging. Radiology 163:117-121, 1987
93. Narumi Y, Kadota T, Inoue E, et al: Bladder tumors: Staging with gadolinium-enhanced oblique MR imaging. Radiology 187:145-150, 1993
94. Neuerburg JM, Bohndorf K, Sohn M, et al: Urinary bladder neoplasms: Evaluation with contrast-enhanced MR imaging. Radiology 172:739-743, 1989
95. Sohn M, Neuerburg J, Teufl F, et al: Gadoliniumenhanced magnetic resonance imaging in the staging of urinary bladder neoplasms. Urol Int 45:142-147, 1990
96. Kim B, Semelka RC, Ascher SM, et al: Bladder tumor staging: Comparison of contrast-enhanced CT, T1 and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology 193:239-245, 1994
97. Scattoni V, Da Pozzo LF, Colombo R, et al: Dynamic gadolinium-enhanced magnetic resonance imaging in staging of superficial bladder cancer. J Urol 155:1594-1599, 1995
98. Husband JES, Olliff JFC, Williams MP, et al: Bladder cancer: Staging with CT and MR imaging. Radiology 173:435-440, 1989
99. Barentsz JO, Jager GJ, van Vierzen PBJ, et al: Staging urinary bladder cancer after transurethral biopsy: Value of fast dynamic contrast enhanced MR imaging. Radiology 201:185-193, 1996
100. Bates TS, Cavanagh PM, Speakman M, et al: Endorectal MRI using a 0.5T mid-field system in the staging of localized prostate cancer. Clin Radiol 51:550-553, 1996
101. Cornud F, Belin X, Flam T, et al: Local staging of prostate cancer by endorectal MRI using fast spin-echo sequences: Prospective correlation with pathological findings after radical prostatectomy. Br J Urol 77:841-850, 1996
102. Bartolozzi C, Caramella D, Zampa V, et al: MR imaging with STIR technique and air insufflation for local staging of bladder neoplasms. Acta Radiol 33:577-581, 1992